Crystalline Solid Forms of BET Inhibitor for Cancer Treatment

The USPTO published patent application US20260092065A1 for crystalline solid forms of BET protein inhibitors (BRD2, BRD3, BRD4, BRD-t) useful in cancer treatment. Seven inventors (Chen, Jia, Liu, Qiao, Wu, Zhou, Li) filed the application on September 23, 2025. The application claims novel solid forms, preparation methods, and intermediates for the therapeutic compound.

Heterocyclic Compounds for Treatment of Disease

USPTO published patent application US20260092064A1 for heterocyclic compounds and compositions for treating disease, filed by inventors Raju Mohan, John Nuss, and Jason Harris on May 14, 2025. The application was published April 2, 2026, covering compounds classified under CPC codes including C07D 471/04, A61K 31/41, and A61P therapeutic categories.

Fused Bicyclic RAF Inhibitors and Methods for Use Thereof

The USPTO published patent application US20260092063A1 for fused bicyclic RAF inhibitors as potential cancer therapeutics, including colorectal cancer treatment. Inventors include Andrew Belfield, Clifford David Jones, Jean-François Margathe, and Chiara Colletto. The application was filed on 2025-05-12 under Application No. 19205876.

Pyridine Carboxamide Compounds for Treating Medical Conditions

The USPTO published patent application US20260092062A1 for pyridine carboxamide compounds and their use in treating medical conditions. The application was filed by inventors Todd Bosanac, Nathan Oliver Fuller, Robert Owen Hughes, Guy Bemis, and Janeta Valentina Popovici Muller on September 26, 2023, and published on April 2, 2026.

Seven inventors file PROTAC protein degradation compounds patent

Seven inventors file PROTAC protein degradation compounds patent

Medical Wire with Flexible Tube and Operation Wire

USPTO published patent application US20260091198A1 for a medical wire assembly including a bendable flexible tube extending front-to-rear, an operation wire inserted within the tube, and a support fixed to the rear end of the tube. The operation wire front end is fixed to the tube front end while displaced radially from the central axis in one direction.

Multi-lumen catheters for fluid delivery

USPTO published patent application US20260091197A1 for multi-lumen catheters and related systems by Cerinfuse Technologies, Inc. The invention covers size-adjustable catheters with guide and fluid lumens, adapter ports, and methods for fluid delivery to tissue or cavities. The application was filed on September 30, 2025.

Provisioning device for storing and transporting catheters

The USPTO published patent application US20260091196A1 for a provisioning device designed to store and transport catheters, specifically balloon catheters for percutaneous transluminal coronary angioplasty. The application, filed by inventors Eberhard Engelien, Fred Held, Verena Desch, and David Rieche, describes a support with holding elements arranged to secure a catheter rolled in an annular manner. Medical device manufacturers developing catheter-related products should review the published claims for potential overlap with existing or planned products.

Intermittent Intravesical Therapeutic Administration System

USPTO published patent application US20260091195A1 for an intermittent intravesical catheter system featuring a dual-lumen design with urinary and instillation lumens, drainage and instillation eyelets, and a slidable sheath for switching between drainage and therapeutic instillation modes. Inventors: Howard Shapland, Scott Glickman, Gabriel Korn. Application No. 19289334.

Methods and User Interfaces for Application-Based Transitions

USPTO published patent application US20260091194A1 covering health application user interfaces with animated interactive graphical objects and virtual transitions. Inventors Jonathan PERRON, Jordan A. CAZAMIAS, and Ryan HOBACK filed Application No. 19224487 on May 30, 2025, which published on April 2, 2026. CPC classifications include A61M 21/02 and G06F 3/011.